Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02728505 · ClinicalTrials.gov registry record · Phase 1
SinuSurf vs. Saline Solution in Normal Subjects
A Phase 1 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT02728505 is a Phase 1 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT02728505, a Phase 1 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Single-center, prospective, placebo controlled trial of tolerability and safety of low-concentration SinuSurf sinus irrigation solution in normal subjects. Forty (40) healthy subjects aged 18-65 will be enrolled in the study.
Interventions
- DRUG SinuSurf irrigation twice daily
- DRUG NeilMed Sinus rinse irrigation twice daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-04-12 |
| Est. Completion | 2017-01-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02728505
The ClinicalTrials.gov registry entry for NCT02728505 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SinuSurf irrigation twice daily is the first listed.
NCT02728505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02728505 about?
NCT02728505 is a clinical study titled "SinuSurf vs. Saline Solution in Normal Subjects". Single-center, prospective, placebo controlled trial of tolerability and safety of low-concentration SinuSurf sinus irrigation solution in normal subjects. Forty (40) healthy subjects aged 18-65 will be enrolled in the study.
What is the current status of trial NCT02728505?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2016-04-12. Estimated completion is 2017-01-20.
What interventions are being tested in trial NCT02728505?
The interventions under investigation include: SinuSurf irrigation twice daily (DRUG), NeilMed Sinus rinse irrigation twice daily (DRUG).
Who is sponsoring clinical trial NCT02728505?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.